Serial single-cell profiling analysis of metastatic TNBC during Nab-paclitaxel and pembrolizumab treatment

PURPOSE: Immunotherapy has recently been shown to improve outcomes for advanced PD-L1-positive triple-negative breast cancer (TNBC) in the Impassion130 trial, leading to FDA approval of the first immune checkpoint inhibitor in combination with taxane chemotherapy. To further develop predictive bioma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Deng, Jiehui, Thennavan, Aatish, Shah, Suhagi, Bagdatlioglu, Ece, Klar, Natalie, Heguy, Adriana, Marier, Christian, Meyn, Peter, Zhang, Yutong, Labbe, Kristen, Almonte, Christina, Krogsgaard, Michelle, Perou, Charles M., Wong, Kwok-Kin, Adams, Sylvia
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170702/
https://ncbi.nlm.nih.gov/pubmed/32949350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05936-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados